Oncotarget

Research Papers:

Mitochondrial targeted HSP90 inhibitor Gamitrinib-TPP (G-TPP) induces PINK1/Parkin-dependent mitophagy

Fabienne C. Fiesel _, Elle D. James, Roman Hudec and Wolfdieter Springer

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:106233-106248. https://doi.org/10.18632/oncotarget.22287

Metrics: PDF 3345 views  |   HTML 5281 views  |   ?  


Abstract

Fabienne C. Fiesel1,2, Elle D. James1, Roman Hudec1 and Wolfdieter Springer1,2

1Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA

2Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL 32224, USA

Correspondence to:

Fabienne C. Fiesel, email: [email protected]

Wolfdieter Springer, email: [email protected]

Keywords: PINK1; parkin; mitophagy; mitochondrial UPR; Gamitrinib

Received: June 02, 2017     Accepted: October 13, 2017     Published: November 06, 2017

ABSTRACT

Loss-of-function mutations in PINK1 or PARKIN are associated with early-onset Parkinson’s disease. Upon mitochondrial stress, PINK1 and Parkin together mediate a response that protects cells from the accumulation of harmful, damaged mitochondria. PINK1, the upstream kinase accumulates on the mitochondrial surface and recruits the E3 ubiquitin ligase Parkin on site to ubiquitylate substrate proteins. The joint activity of both to generate phosphorylated poly-ubiquitin chains on the mitochondrial surface induces the recruitment of autophagy receptors and eventually whole organelles are cleared by autophagy. While this pathway is generally accepted to occur upon chemical uncoupling of mitochondria, the (patho-) physiologic relevance has been questioned. However, few studies have indicated that PINK1 and Parkin are also activated upon accumulation of misfolded proteins in the mitochondrial lumen upon overexpression of ΔOTC (Ornithine transcarbamylase). Here, we used the mitochondrial targeted HSP90 inhibitor Gamitrinib-triphenylphosphonium (G-TPP), an anti-cancer agent, to chemically interfere with mitochondrial protein folding. G-TPP treatment induced PINK1 accumulation, ubiquitin phosphorylation at Ser65, Parkin activation and its recruitment to mitochondria was specific for mitochondrial HSP90 inhibition and largely independent of mitochondrial membrane depolarization. Mitophagy induction was observed by monitoring autophagy receptor recruitment and the mitoKeima reporter. Importantly, mitophagy was not only induced in cancer cells but also in primary human fibroblasts and thereof converted neurons. G-TPP treatment might represent a novel strategy to study PINK1 and Parkin-mediated mitochondrial quality control using a more physiologically relevant stress.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22287